Granulocyte-macrophage colony-stimulating factor and interleukin-1 increase in cerebrospinal fluid, but not in serum, of HTLV-I-associated myelopathy
- 30 June 1993
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 45 (1-2) , 133-136
- https://doi.org/10.1016/0165-5728(93)90173-v
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathyJournal of Neuroimmunology, 1993
- Rapid Development of Myelopathy after HTLV-I Infection Acquired by Transfusion during Cardiac TransplantationNew England Journal of Medicine, 1990
- Suppression of tuberculin skin reaction in healthy HTLV‐I carriers from JapanInternational Journal of Cancer, 1988
- Activated t‐lymphocytes with polyclonal gammopathy in patients with human t‐lymphotropic virus type i—associated myelopathyAnnals of Neurology, 1988
- A unifying model of the immunoregulatory role of the interferon system: Can interferon produce disease in humans?Clinical Immunology and Immunopathology, 1987
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Chronic progressive myelopathy associated with elevated antibodies to human T‐lymphotropic virus type I and adult T‐cell leukemialike cellsAnnals of Neurology, 1987
- Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulinNature, 1986
- Interleukin-1 and the Pathogenesis of the Acute-Phase ResponseNew England Journal of Medicine, 1984
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.The Journal of Experimental Medicine, 1984